5 unknown, 3 completed. 3 Phase 2, 2 Phase 4, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 2, Completed 1 |
| Phase 4 | 2 | Unknown 2 |
| Not applicable | 1 | Unknown 1 |
Follow Genes, p53: new trials by email Literature Review of Genes, p53 trials Research Report on Genes, p53
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Use of Immunohistochemical Staining for the Prediction of Wilms Tumour Progression and Recurrence P53, Ki67 and Cyclin A IHC. - Wilms Tumor, Relapse | Not applicable | Unknown | Mansoura University | 75 | 2021-02-14 | 2021-02-17 |
| Association Between Ferroptosis and Epilepsy SLC7A11, GPX4, P53 - Epilepsy | Completed | Affiliated Hospital of Jiangnan University | 40 | 2021-01-20 | 2022-04-15 | |
| Signaling Pathways Targeting Colorectal Cancer in Egypt Markers in tissue samples: (TIGAR , TRIM59, P53, AKT, GSH) - Colorectal Cancer | Completed | Assiut University | 180 | 2018-03-01 | 2020-05-11 | |
| p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer p53 gene, Cisplatin, Paclitaxel - Ovarian Epithelial Cancer, Fallopian Tube Cancer | Phase 2 | Unknown | Shenzhen SiBiono GeneTech Co.,Ltd | 100 | 2015-06-01 | 2015-05-06 |
| Trans-catheter Arterial Embolization Combined With p53 Gene Therapy for Treatment of Advanced Hepatocellular Carcinoma TAE plus P53 gene, TAE - Advanced Hepatocellular Carcinoma (HCC) | Phase 2 | Unknown | Shenzhen SiBiono GeneTech Co.,Ltd | 60 | 2014-10-01 | 2015-07-27 |
| rAd-p53 Gene Therapy for Advanced Oral and Maxillofacial Malignant Tumors p53 gene with surgery, surgery, p53 with chemotherapy - Advanced Oral and Maxillofacial Malignant Tumors | Phase 4 | Unknown | Shenzhen SiBiono GeneTech Co.,Ltd | 600 | 2009-06-01 | 2012-04-09 |
| p53 Gene Therapy for Head and Neck Malignant Tumors in Advanced Stage chemotherapy plus p53, chemotherapy, radiotherapy - Neoplasms | Phase 4 | Unknown | Shenzhen SiBiono GeneTech Co.,Ltd | 1200 | 2009-05-01 | 2012-04-09 |
| Phase II Study of Metastatic Cancer That Overexpresses P53 Using Lymphodepleting Conditioning Followed by Infusion of Anti-P53 TCR-Gene Engineered Lymphocytes anti-protein 53 or tumor protein 53 (p53) T-cell receptor transduced peripheral blood lymphocytes, aldesleukin, filgrastim - Anti-p53 TCR-Gene | Phase 2 | Completed | National Cancer Institute (NCI) | 12 | 2006-10-01 | 2011-08-15 |
Neoplasms (3) · Recurrence (2) · Carcinoma, Ovarian Epithelial (1) · Carcinoma, Renal Cell (1) · Colorectal Neoplasms (1) · Death (1) · Epilepsy (1) · Fallopian Tube Neoplasms (1) · Neoplasm Metastasis (1) · Ovarian Neoplasms (1) · Wilms Tumor (1)
Shenzhen SiBiono GeneTech Co.,Ltd (4) · Affiliated Hospital of Jiangnan University (1) · Assiut University (1) · Mansoura University (1) · National Cancer Institute (NCI) (1)
China (5) · Egypt (2) · United States (1)
Adel Nabeeh, MD (1) · Ahmed Ali Abdel Motelb, lecturer (MD) (1) · Ashraf Hafez, MD (1) · Asmaa Alaaeldeen Kamal, MD (PhD student) (1) · Longjiang Li, PhD, MD (1) · Marwa AbdelHafiz Abdel Hassan, lecturer (MD) (1) · Mohamed Abdelhameed, MSc (1) · Ragaa Hamdy Salama, Professor (MD) (1) · Steven A Rosenberg, M.D., Ph.D (1) · Tamer Helmy, MD (1) · YueYing Liu (1)